Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Gross Margin

Acadia Pharmaceutica Gross Margin Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Acadia Pharmaceutica Gross Margin for the quarter ending June 06, 2020 was $37m a 21.28% increase of 8m year over year
  • Acadia Pharmaceutica Gross Margin for the last 12 months ending June 06, 2020 was $29m a 42.66% increase of 13m year over year
  • Acadia Pharmaceutica Annual Gross Margin for 2019 was $23m a 64.92% increase of 15m from 2018
  • Acadia Pharmaceutica Annual Gross Margin for 2018 was $8m a 465.42% increase of 38m from 2017
  • Acadia Pharmaceutica Annual Gross Margin for 2017 was $-30m a -1,566.42% increase of 468m from 2016
Other Margins & Efficiency Metrics:
  • Acadia Pharmaceutica EBITDA Margin for the quarter ending December 12, 2018 was $-112m a 0.94% decrease of -1m year over year
  • Acadia Pharmaceutica Return on Capital % for the quarter ending September 09, 2018 was -62.76 a 23.01% decrease of -14.44 year over year
  • Acadia Pharmaceutica Return on Equity % for the quarter ending September 09, 2018 was -101.83 a 24.07% decrease of -24.52 year over year
View Chart On Koyfin

Quarterly ACAD Gross Margin Data

06/2020$37m
03/2020$14m
12/2019$36m
09/2019$29m
06/2019$13m
03/2019$9m
12/2018$12m
09/2018$0m
06/2018$9m
03/2018$12m

Annual ACAD Gross Margin Data

2019$23m
2018$8m
2017$-30m
2016$-498m
2015$-125,095m
2014$-50,402m
2013$-2,234m
2012$-283m
2011$-737m
2010$51m